Lindahl advised Nanologica on the offering. Nanologica finalized a rights issuance, which was resolved by the board of directors on 29 August 2024 and approved by...
Nanologica AB’s Rights Offering
Nanologica AB’s Uplisting on Nasdaq Stockhol Main Market
Lindahl advised Nanologica AB on the deal. Nanologica AB announced the company’s list change from Spotlight Stock Market to Nasdaq Stockholm’s main market. Nanologica manufactures, develops, and...